Exclusive Industry Insights

Posted on

Big Pharma Strategic Partnerships

I was thrilled to see MannKind and Sanofi’s announcement regarding their licensing agreement to bring Afrezza to marke...

Read More »

Posted on

Preparing Amarantus for the Up-list in 2...

On Friday, August 8th, 2014, we filed a preliminary proxy statement with the United States Securities and Exchange Commi...

Read More »

Posted on

Lipidomics – An Exciting Foundation fo...

Dear Readers, Welcome to the inaugural Matinas BioPharma CEO Blog! I am very excited to share some of our learning’...

Read More »

Posted on

#C4CT Wrap-up and the Decision to Presen...

The month of July turned out to be an incredible fundamental value-building month for Amarantus. We completed our 3rd #C...

Read More »

Posted on

Expanding the Treatment Options

As the head of AntriaBio’s clinical efforts as well as a practicing Endocrinologist, I am delighted our CEO, Nevan Ela...

Read More »

Posted on

Is Stevia Better than Puma’s Neratinib...

First, welcome back, and thanks for staying engaged.  It’s always a pleasure to share updates and insights about our ...

Read More »

Reveal Insights About Your Company and Industry to Shareholders.

The Chairman's Blog is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. The Chairman's Blog enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. Learn More »